Wave Life Sciences Pte. Ltd(WVE)

盘后14.450.000.00%16:02 EDT

14.45-0.37-2.50%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
Wave Life Sciences Pte. Ltd
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.wavelifesciences.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Wave Life Sciences Ltd.于2012年7月23日在新加坡注册成立。该公司是一家临床生物制药公司，以创新和专有合成化学药物开发平台，使用的设计，开发和商业化的先入类或最佳的类核酸治疗考生广泛的管道。核酸治疗有解决那些难以治疗与小分子药物和生物制剂的潜力，并已成为一个庞大而有前途的一类药物。公司最初开发核酸治疗剂靶向的遗传缺陷要么减少疾病促进蛋白质的表达或改造生产失调突变蛋白进入生产的功能性蛋白质。该公司的平台是由其创新和专有立体技术的推动，使之合理设计，优化和制造stereopure核酸治疗，它认为具有药物属性优于寡核苷酸的立体异构体混合物，目前市场上还是处在发展中。
- 10-16
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 10-16
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 10-16
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 10-15
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 10-01
  超过5%披露
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
- 10-01
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 09-26
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 09-25
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 09-24
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 08-21
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 08-12
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 08-08
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 08-08
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 06-25
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-10
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]